zanidatamab-hrii 300 MG Injection
- RxCUI
- 2698206
- RxNorm name
- zanidatamab-hrii 300 MG Injection
- Display name
- zanidatamab-hrii 300 MG Injection
- Full name
- zanidatamab-hrii 300 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:15
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761416 | Ziihera | zanidatamab-hrii | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZIIHERA | ZANIDATAMAB-HRII | Jazz Pharmaceuticals, Inc. | ae5d9425-fae5-4541-a158-150998343348 | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | 2698206 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ae5d9425-fae5-4541-a158-150998343348 | zanidatamab-hrii 300 MG Injection [PSN] · zanidatamab-hrii 300 MG Injection [SCD] | 2 | 2 | These highlights do not include all the information needed to use ZIIHERA safely and effectively. See full prescribing information for ZIIHERA. ZIIHERA ® (zanidatamab‑hrii) for injection, for intravenous use. Initial U.S. Approval: 2024 | 20250701 |